Retina implants: location is key

March 24, 2010 by Pete Wilton, Oxford University
Healthy human retina by Michael Judge Brislin via Wikimedia Commons.

(PhysOrg.com) -- The first UK trial of a promising new retinal implant technique is to be led by Oxford University researchers.

The technology, developed by the firm , AG, involves implanting a device underneath a patient's retina.

The device itself is light sensitive, with a 1,500 pixel array, and is stimulated by the natural image focused by the eye - eliminating the need for an external camera (typically mounted on spectacles).

Retinal implants hold particular promise for the treatment of retinitis pigmentosa (RP) a form of inherited affecting approximately 200,000 people worldwide that typically causes severe in adulthood.

The trial will be led by Professor Robert MacLaren of Oxford University's Nuffield Laboratory of Opthalmology. 'I have been working in developing new treatments for patients with retinal diseases for many years and I was initially sceptical about the role of electronic devices,' he said.

'However, this recent work by the Retina Implant team is very impressive indeed and I would now certainly consider this technology as a viable treatment option for patients blind from RP.'

He described it as 'much more logical' to implant a device underneath the retina, as this is 'where the residual neurons are orientated towards the implant electrodes, because this should equate to a much higher pixel resolution.'

Making the implant itself light sensitive is, he believes, a major advance 'because the whole device can be contained within the eye. A power supply is fed through a battery behind the ear similar to a hearing aid.'

'This represents a true fusion of an electronic interface with the human and we are likely now to learn a lot more about this technology as the trial progresses.'

The Oxford-led clinical trial using the technology, which will take place at the John Radcliffe Hospital, is due to start later this year.

Related Stories

Recommended for you

A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder

September 21, 2018
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic ...

Japanese team creates human oogonia using human stem cells in artificial mouse ovaries

September 21, 2018
A team of researchers with members from several institutions in Japan has successfully generated human oogonia inside of artificial mouse ovaries using human stem cells. In their paper published in the journal Science, the ...

Researchers explore how changes in diet alter microbiome in artificial intestine

September 21, 2018
Using an artificial intestine they created, researchers have shown that the microbiome can quickly adapt from the bacterial equivalent of a typical western diet to one composed exclusively of dietary fats. That adaptation ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Study identifies stem cell that gives rise to new bone and cartilage in humans

September 20, 2018
A decade-long effort led by Stanford University School of Medicine scientists has been rewarded with the identification of the human skeletal stem cell.

Scientists grow human esophagus in lab

September 20, 2018
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.